Abbott vs. Medtronic: Is Consistent Growth Better Than a Turnaround Story?
Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both prominent names in the Medtech space.
Posts Tagged ‘NYSE:ABT’
Abbott vs. Thermo Fisher: Is Diversification or the Life Sciences Recovery the Better Bet?
Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics...
Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?
Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 billion, above analysts' average estimate of about...
What Makes Abbott Laboratories (ABT) a Compelling Investment Opportunity with Reliable Growth
Matrix Asset Advisors, an asset management company, released its Q2 2026 investor letter. A copy of the letter can be downloaded here.
Abbott vs Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?
Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics...
Abbott (ABT) Raised Its Profit Forecast. What’s Driving Its Growth?
Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics...
Abbott Laboratories (ABT) Fell as Guidance and Litigation Concerns Overshadowed Growth
Jensen Investment Management, an asset management company based in the US, released its second-quarter 2026 investor letter for the "Jensen Quality Growth Equity Strategy".
12 Best Monopoly Stocks to Buy According to Hedge Funds
RBC Wealth Management noted that the consensus 2026 earnings growth forecast for the S&P 500 saw an increase from 13.6% at the start of the year to 23.3% by the end of June.
Is Abbott Laboratories (ABT) Stock Still a Healthcare Growth Opportunity After Analyst Target Cut?
TheFly reported on July 6 that Evercore ISI analyst Vijay Kumar reduced the firm’s price target on Abbott Laboratories to $112 from $120 while maintaining an Outperform rating...
10 Best Innovative Healthcare Stocks to Buy Now
The U.S. healthcare sector has lagged behind the entire market for three consecutive years, with returns of just 0.3% in 2023, 0.9% in 2024, and 12.5% in 2025.
10 Best Brain-Computer Interface Stocks to Buy
On May 10, Bloomberg reported that brain-computer interfaces are transitioning from experimental to early implementation, allowing users to control computers, robotic arms, and...
Top 10 Stocks to Buy for Financial Stability
On June 17, 2026, the Fed held interest rates steady as expected, but new Chair Kevin Warsh's first policy statement stripped out forward guidance on future rate moves, blindsiding...
Dividend Stock Portfolio: Top 10 Stocks to Buy According to Reddit
In May, Forbes reported that retail investors are continuing to put money into the market even as geopolitical tensions increase and market volatility edges higher.
10 Best Bargain Stocks to Buy in June
On June 8, Reuters reported that Citigroup raised its 2026 year-end target for the S&P 500 index to more than 8,100, thanks to corporate earnings and AI-driven growth.
7 Best Longevity Stocks to Buy Now
Longevity stocks are getting more attention as investors look for companies tied to longer lifespans, healthier aging, and rising demand for care.
10 Deep Value Stocks to Invest In Now
Value stocks are on the move, after years of underperformance, amid heightened market volatility and a shift away from mega-cap concentration.
Abbott (ABT) Secures CE Mark for World’s First Dual Glucose‑Ketone Sensing Technology for Diabetes
Abbott Laboratories (NYSE:ABT) is one of the best healthcare stocks to buy with highest upside potential.
10 Best Blue Chip Stocks Under $100 to Buy Now
As per Columbia Threadneedle Investments, the broader markets seem to be significantly resilient amidst the Middle East conflict.
10 Best Healthcare Stocks to Buy with Highest Upside Potential
On June 1, Tom Lee, Fundstrat managing partner and head of research, and Fundstrat Capital CIO, appeared on CNBC’s ‘Squawk Box’ to talk about the latest market trends, the...
Jim Cramer Talked About 16 Stocks Like Micron and Dell, Along With the AI Infrastructure Spending
In this article, we will look at the stocks Jim Cramer discussed during his recent rally discussion in several AI-related stocks.
Why Investors Are Cautious on Abbott Laboratories (ABT)?
The Mairs & Power, an investment firm, released the first-quarter 2026 investor letter for the “Mairs & Power Balanced Fund.” A copy of the letter can be downloaded here.
Abbott Laboratories (ABT) Slid on Headwinds in Nutrition Business
Diamond Hill Capital, a First Eagle Investment Management company, issued its Q1 2026 investor letter for its “Large Cap Strategy”. A copy of the letter is available to...
11 Best Medical Technology Stocks to Buy Right Now
One of the key conclusions in EY’s 19th annual Pulse of the MedTech Industry Report is that the global medical technology market has moved from a period of post-pandemic turbulence...
Abbott Laboratories (ABT) Slid Due To Its Nutrition Segment’s Sensitivity to Consumer Spending Momentum
Carillon Tower Advisers, an investment management company, released its first-quarter 2026 investor letter for the “Carillon Eagle Growth & Income Fund”. A copy of the letter...
Waiting on Integration Result, Market Stays Moderated on Abbott Laboratories (ABT)
Alpha Wealth Funds, LLC, an investment management company, released its Q1 2025 letter for the “Insiders Fund”. A copy of the letter can be downloaded here.
Jim Cramer’s Take on 24 Stocks: Cisco, Eli Lilly, and Ford
In this article, we will look at the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up for this market.
Abbott Laboratories (ABT) Receives FDA Clearance and CE Mark for Next-Generation Ultreon™ 3.0 Software
Abbott Laboratories (NYSE:ABT) is one of the best medical device stocks to invest in right now. Abbott Laboratories (NYSE:ABT) announced on April 28 that it received the U.S.
Here’s Why Polen Focus Growth Exited Abbott Laboratories (ABT) in Q1
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first-quarter 2026 investor letter. A copy of the letter can be downloaded here...
10 Best Medical Device Stocks to Invest In Right Now
On April 27, Tom Lee, Fundstrat Capital Chief Investment Officer and Bitmine Immersion Technologies Chairman, appeared on CNBC's ‘Power Lunch’ to discuss the outlook for equity...
10 Best Bear Market Stocks to Invest In Right Now
A stock index is considered to be in a bear market when its closing price falls at least 20% from its most recent high.
Abbott Laboratories (NYSE:ABT) Q1 2026 Earnings Call Transcript
Operator: Good morning, and thank you for standing by. Welcome to Abbott Laboratories' First Quarter 2026 Earnings Conference Call.
12 Oversold Blue Chip Stocks to Buy According to Analysts
Oversold blue chip stocks are drawing a closer look, but not just because they have fallen.
Jim Cramer’s Game Plan for 12 Stocks and His Take on the Market Post Iran-U.S. Ceasefire Talks
In this article, we will look at the stocks on Jim Cramer’s game plan as he shared his take on the market post-Iran-U.S. ceasefire talks.
15 Best Consistent Dividend Stocks to Buy Right Now
According to an April 6 report by CNBC, if the Iran war drags on longer than expected, investors may want to look at defensive stocks that pay dividends, according to Jefferies...
Conservative Stock Portfolio: 7 Best Stocks to Buy Right Now
On March 24, Reuters reported that Barclays raised its 2026 year-end S&P 500 target on the heels of robust corporate earnings, thanks to the broader technology sector and resilience...
Abbott (ABT) Stock Rated Buy on Strong Diabetes Trial Results
Abbott Laboratories (NYSE:ABT) ranks among the best most active stocks to buy right now.
12 Best Most Active Stocks to Buy Right Now
Recent market volatility has unnerved investors, but not all analysts are turning negative just yet.
Is Abbott Laboratories (ABT) A Good Stock To Buy Now?
Is ABT a good stock to buy? We came across a bullish thesis on Abbott Laboratories on Compounding Dividends’s Substack by TJ Terwilliger.
Abbott Laboratories (ABT) Unveils XIENCE Skypoint to Advance Cardiovascular Treatment in India
Abbott Laboratories (NYSE:ABT) is one of Goldman Sachs top healthcare stocks.
Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
The healthcare sector, long seen as a laggard amid the artificial intelligence boom, is beginning to turn the corner.
Abbott Laboratories (ABT) Likely to Benefit From Nutrition Segment Recovery
On February 2, the price target on Abbott Laboratories (NYSE:ABT) was reduced from $169 to $142 by Barclays analyst Matt Miksic.
10 Best Healthcare Equipment Stocks to Buy According to Hedge Funds
The Healthcare Equipment segment is one of the areas across the broader healthcare landscape that carries immense innovation prospects and also offers a defensive play.
Abbott Laboratories (ABT) Announces Positive Results for Amulet 360 Left Atrial Appendage (LAA) Occlude
Abbott Laboratories (NYSE:ABT) is one of the Best Dip Stocks to Buy According to Hedge Funds.
11 Best Dip Stocks to Buy According to Hedge Funds
On February 17, Mohamed El-Erian, Chief Economic Advisor at Allianz, appeared on a CNBC Television interview to discuss the way forward amidst the volatility.
Abbott Laboratories (ABT): Short-Term Headwinds, Strategic Pipeline Strength, and UBS Buy Rating
Abbott Laboratories (NYSE:ABT) is one of the best 52-week low blue-chip stocks to buy right now.
10 Best 52-Week Low Blue Chip Stocks to Buy Right Now
The S&P 500 has performed exceedingly well over the past two years, powering to all-time highs amid easing inflation and the artificial intelligence boom.
Abbott (ABT) Faces Profit Headwinds as Pediatric Nutrition Remains Under Pressure
A Reuters report said Abbott Laboratories (NYSE:ABT) warned that its current-quarter profit would come in below expectations after the company also fell short of Wall Street’...
Abbott Laboratories (ABT): A Bull Case Theory
We came across a bullish thesis on Abbott Laboratories on R. Dennis’s SubstackR. Dennis’s Substack by OppCost.
Dividend Growth Stocks: 25 Aristocrats
Dividend aristocrats are companies that have raised their dividends every year for at least 25 years.
13 Best 52-Week Low Stocks to Invest In
On January 27, Sherry Paul, a senior portfolio manager at Morgan Stanley, appeared on a CNBC Television interview to discuss the state of the markets and concerns about volatility...
Hedge Fund Resource Center
